Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Author:

Pappa Christina1,Galaal Khadra2,Smyth Sarah1,Bristow Robert E3,Khashan Ali S4,Alazzam Mo'iad1

Affiliation:

1. Gynaecological Oncology Division; Oxford University Hospitals; Oxford UK

2. Surgical Oncology Department; Sultan Qaboos Comprehensive Cancer Centre SQCCCRC; Muscat Oman

3. Division of Gynecologic Oncology; University of California - Irvine, Medical Center; Orange CA USA

4. School of Public Health; University College Cork; Cork Ireland

Publisher

Wiley

Reference55 articles.

1. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology;Aaronson;Journal of the National Cancer Institute,1993

2. Surgical cytoreduction for recurrent epithelial ovarian cancer;Al Rawahi;Cochrane Database of Systematic Reviews,2013

3. Predicting prognosis and platinum resistance in ovarian cancer: role of immunohistochemistry biomarkers;Atallah;International Journal of Molecular Sciences,2023

4. The systemic treatment of recurrent ovarian cancer revisited;Baert;Annals of oncology : official journal of the European Society for Medical Oncology,2021

5. Reliability and validity of the functional assessment of cancer therapy - ovarian;Basen-Engquist;The Journal of Clinical Oncology,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3